Sr Vice President, Pharma Business Development
Currentwww.Owkin.com is the worlds leader in providing unprecedented federated learning, AI/ ML technologies to accelerate Medical & Clinical Research - focused solely on Life Sciences.Owkin leverages life science, AI (artificial intelligence) and machine learning (ML) expertise to make drug development and clinical trial design both more targeted and more cost effective. Owkin applies cutting-edge machine learning algorithms across a broad network of the largest academic medical centers in EU and US, creating dynamic models that can not only predict disease evolution and treatment outcomes, but also be used in clinical trials for enhanced analysis, high-value subgroup identification, identification of novel biomarkers, and the creation of both synthetic control arms and surrogate endpoints. Through this network, Owkin can interrogate heterogeneous real-world data hand-in-hand with world class clinicians to interpret model features and discover and validate novel multimodal biomarkers, all the while preserving patient privacy. Unlike traditional "pooled" data, the data does not move, only algorithms travel - The end result is Better treatments for patients, developed faster, and at a lower cost backed via a unique unmatched Federated Learning Model.